These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 341229)

  • 1. Effects of 13, 14-dehydroprostacyclin methyl ester on the feline intestinal vascular bed.
    Paustian PW; Chapnick BM; Feigen LP; Hyman AL; Kadowitz PJ
    Prostaglandins; 1977; 14(6):1141-52. PubMed ID: 341229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids.
    Hyman AL; Chapnick BM; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5711-5. PubMed ID: 414226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids.
    Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.
    Hyman AL; Kadowitz PJ
    Circ Res; 1979 Sep; 45(3):404-9. PubMed ID: 110490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular actions of prostacyclin (PGI2) in the cat.
    Lippton HL; Paustian PW; Mellion BT; Nelson PK; Feigen LP; Chapnick BM; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):121-30. PubMed ID: 393193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of PGD2 and PGE2 in the regional circulation of the cat.
    Lippton HL; Paustian PW; Sporl L; Kadowitz PJ
    Prostaglandins Med; 1980 Nov; 5(5):365-73. PubMed ID: 7454886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of prostaglandins E2 and I2 on rat renal vascular resistance.
    Baer PG; McGiff JC
    Eur J Pharmacol; 1979 Mar; 54(4):359-63. PubMed ID: 374096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of PGD2 and PGE2 on vasoconstrictor responses in the feline intestinal vascular bed.
    Lippton HL; Cassin S; Kadowitz PJ
    Prostaglandins Med; 1980 Oct; 5(4):297-305. PubMed ID: 7443875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vasodilator responses to vasoactive intestinal peptide in the cat.
    Nandiwada PA; Kadowitz PJ; Said SI; Mojarad M; Hyman AL
    J Appl Physiol (1985); 1985 May; 58(5):1723-8. PubMed ID: 3997734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of vasoconstrictor and vasodilator responses by PGE1 in the intestinal vascular bed of the cat.
    Lippton HL; Kadowitz PJ
    Prostaglandins Med; 1981 Dec; 7(6):537-52. PubMed ID: 6798592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2.
    Kadowitz PJ; Chapnick BM; Feigen LP; Hyman AL; Nelson PK; Spannhake EW
    J Appl Physiol Respir Environ Exerc Physiol; 1978 Sep; 45(3):408-13. PubMed ID: 359514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary vascular responses to prostaglandins.
    Kadowitz PJ; Gruetter CA; Spannhake EW; Hyman AL
    Fed Proc; 1981 May; 40(7):1991-6. PubMed ID: 7014258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin.
    Hatano Y; Kohli JD; Goldberg LI; Fried J; Mehrotra MM
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6846-50. PubMed ID: 7005902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the termination of cardiovascular actions of 10,10-difluoro,13-dehydroprostacyclin.
    Powell JR; Kerwin LJ; McGill MH; Haslanger M; Fried J
    Prostaglandins; 1983 Mar; 25(3):457-67. PubMed ID: 6408713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of alpha-MSH and several vasoactive substances on vascular resistance in the feline mesenteric vascular bed.
    Kadowitz PJ; Chapnick BM; Kastin AJ
    Pharmacol Biochem Behav; 1976 Aug; 5(2):219-21. PubMed ID: 825886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vasoconstrictor responses by prostacyclin (PGI2) in the feline mesenteric vascular bed.
    Lippton HL; Chapnick BM; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):214-23. PubMed ID: 393194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the potencies of some prostaglandins as vasodilators in three vascular beds of the anaesthetised dog.
    Lumley P; Humphrey PP; Kennedy I; Coleman RA
    Eur J Pharmacol; 1982 Jul; 81(3):421-30. PubMed ID: 6749531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of prostacyclin (PGI2) on adrenergic neuroeffector transmission in the rabbit kidney.
    Hedqvist P
    Prostaglandins; 1979 Feb; 17(2):249-58. PubMed ID: 220676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose intrarenal infusions of PGE2, PGI2, and 6-keto-PGE1 vasodilate the in vivo rat kidney.
    Jackson EK; Heidemann HT; Branch RA; Gerkens JF
    Circ Res; 1982 Jul; 51(1):67-72. PubMed ID: 7044603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.